Clinical Trials Directory

Trials / Completed

CompletedNCT06475157

Artificial Intelligence-enhanced Electrocardiogram Diagnoses and Predicts Future Regurgitant Valvular Heart Diseases

Artificial Intelligence-enhanced Electrocardiogram Diagnoses and Predicts Future

Status
Completed
Phase
Study type
Observational
Enrollment
500,000 (actual)
Sponsor
Shanghai Zhongshan Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a retrospective study to establish models for the prediction of future valvular heart diseases with artificial intelligence-enhanced electrocardiogram (ECG).

Conditions

Interventions

TypeNameDescription
OTHERNo interventionNo intervention is applied.

Timeline

Start date
2024-03-01
Primary completion
2024-05-30
Completion
2024-05-30
First posted
2024-06-26
Last updated
2024-07-05

Locations

2 sites across 2 countries: China, United Kingdom

Source: ClinicalTrials.gov record NCT06475157. Inclusion in this directory is not an endorsement.

Artificial Intelligence-enhanced Electrocardiogram Diagnoses and Predicts Future Regurgitant Valvular Heart Diseases (NCT06475157) · Clinical Trials Directory